Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

     
[X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.

For the Quarterly Period Ended June 29, 2003

OR

     
[  ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934.

For the transition period from           to

Commission File Number 0-24758

Micro Linear Corporation

(Exact name of Registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of
incorporation or organization)
  94-2910085
(I.R.S. Employer
Identification Number)
     
2050 Concourse Drive
San Jose, California

(Address of principal executive offices)
  95131
(Zip Code)

Registrant’s telephone number, including area code:
(408) 433-5200

     Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  [X]  No  [  ]

     Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes  [  ]  No  [X]

     The number of shares of the Registrant’s Common Stock outstanding as of August 11, 2003, net of shares held in treasury, was 12,250,963.



 


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONSOLIDATED CONDENSED BALANCE SHEETS
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Item 4. Controls and Procedures
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
INDEX TO EXHIBITS
EXHIBIT 31.1
EXHIBIT 31.2
EXHIBIT 32.1
EXHIBIT 32.2


Table of Contents

TABLE OF CONTENTS

                 
            PAGE
           
PART I  
FINANCIAL INFORMATION
       
Item 1.  
Financial Statements (Unaudited)
    3  
       
Consolidated Condensed Balance Sheets at June 30, 2003 and December 31, 2002
    3  
       
Consolidated Condensed Statements of Operations for the three and six months ended June 30, 2003 and 2002
    4  
       
Consolidated Condensed Statements of Cash Flows for the six months ended June 30, 2003 and 2002
    5  
       
Notes to Consolidated Condensed Financial Statements
    6  
Item 2.  
Management’s Discussion and Analysis of Financial Condition and Results of Operations
    10  
Item 3.  
Quantitative and Qualitative Disclosures about Market Risk
    23  
Item 4.  
Controls and Procedures
    24  
PART II  
OTHER INFORMATION
       
Item 1.  
Legal Proceedings
    24  
Item 6.  
Exhibits and Reports on Form 8-K
    25  
SIGNATURES     26  

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

MICRO LINEAR CORPORATION
CONSOLIDATED CONDENSED BALANCE SHEETS
(IN THOUSANDS)

                       
          June 30,   December 31,
          2003   2002
         
 
          (Unaudited)        
Assets
               
Current assets:
               
 
Cash and cash equivalents
  $ 6,389     $ 10,801  
 
Short-term investments
    12,605       14,704  
 
Accounts receivable, less allowance for doubtful accounts of
               
   
$108 at June 30, 2003 and $58 at December 31, 2002
    2,504       1,015  
 
Inventories
    2,870       2,212  
 
Other current assets
    616       2,171  
 
 
   
     
 
   
Total current assets
    24,984       30,903  
Property, plant and equipment, net
    7,688       8,092  
Other assets
    26       27  
 
 
   
     
 
     
Total assets
  $ 32,698     $ 39,022  
 
 
   
     
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
 
Accounts payable
  $ 2,713     $ 2,076  
 
Accrued compensation and benefits
    687       834  
 
Deferred revenue
    1,206       2,045  
 
Accrued commissions
    97       163  
 
Other accrued liabilities
    1,358       1,291  
 
Current portion of long-term debt
    273       239  
 
 
   
     
 
   
Total current liabilities
    6,334       6,648  
Long-term debt
    1,901       2,064  
 
 
   
     
 
     
Total liabilities
    8,235       8,712  
 
 
   
     
 
Stockholders’ equity:
               
 
Common stock
    15       15  
 
Additional paid-in capital
    60,468       60,352  
 
Accumulated deficit
    (15,797 )     (9,848 )
 
Accumulated other comprehensive income
    10       24  
 
Treasury stock
    (20,233 )     (20,233 )
 
 
   
     
 
   
Total stockholders’ equity
    24,463       30,310  
 
 
   
     
 
     
Total liabilities and stockholders’ equity
  $ 32,698     $ 39,022  
 
 
   
     
 

See accompanying notes to unaudited consolidated condensed financial statements.

3


Table of Contents

MICRO LINEAR CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
(UNAUDITED)

                                       
          THREE MONTHS ENDED   SIX MONTHS ENDED
          June 30,   June 30,
         
 
          2003   2002   2003   2002
         
 
 
 
Net revenue
  $ 6,342     $ 8,884     $ 11,034     $ 14,475  
Cost of revenue
    3,804       3,768       6,008       6,239  
 
   
     
     
     
 
 
Gross margin
    2,538       5,116       5,026       8,236  
 
   
     
     
     
 
Operating expenses:
                               
 
Research and development
    2,845       4,094       5,765       8,268  
 
Selling, general and administrative
    2,046       2,247       4,270       4,087  
 
Restructuring charges
    954             954        
 
   
     
     
     
 
     
Total operating expenses
    5,845       6,341       10,989       12,355  
 
   
     
     
     
 
 
Loss from operations
    (3,307 )     (1,225 )     (5,963 )     (4,119 )
Interest and other income
    63       142       158       437  
Interest and other expense
    (35 )     (65 )     (94 )     (134 )
 
   
     
     
     
 
 
Loss before income taxes
    (3,279 )     (1,148 )     (5,899 )     (3,816 )
Provision for income taxes
    23       2       50       79  
 
   
     
     
     
 
 
Net loss
  $ (3,302 )   $ (1,150 )   $ (5,949 )   $ (3,895 )
 
   
     
     
     
 
Net Loss Per Share:
                               
Basic and Diluted
                               
   
Net loss per share
  $ (0.27 )   $ (0.10 )   $ (0.49 )   $ (0.32 )
 
   
     
     
     
 
   
Weighted average number of shares used in per share computation
    12,213       12,064       12,204       12,063  
 
   
     
     
     
 

See accompanying notes to unaudited consolidated condensed financial statements.

4


Table of Contents

MICRO LINEAR CORPORATION
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)

                     
        SIX MONTHS ENDED
        June 30,
       
        2003   2002
       
 
Net cash used in operating activities
  $ (6,011 )   $ (3,722 )
Cash flows from investing activities:
               
 
Purchase of capital equipment
    (471 )     (95 )
 
Purchases of short-term investments
    (6,973 )     (4,549 )
 
Sales of short-term investments
    9,058       7,091  
 
   
     
 
   
Net cash provided by investing activities
    1,614       2,447  
Cash flows from financing activities:
               
 
Principal payments on debt
    (129 )     (120 )
 
Proceeds from issuance of common stock
    114       36  
 
   
     
 
   
Net cash used in financing activities
    (15 )     (84 )
 
   
     
 
 
Net decrease in cash and cash equivalents
    (4,412 )     (1,359 )
 
Cash and cash equivalents at beginning of period
    10,801       14,888  
 
   
     
 
   
Cash and cash equivalents at end of period
  $ 6,389     $ 13,529  
 
   
     
 

See accompanying notes to unaudited consolidated condensed financial statements.

5


Table of Contents

MICRO LINEAR CORPORATION

NOTES TO UNAUDITED CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

1.   Organization and Summary of Significant Accounting Policies

Organization

     Micro Linear develops integrated circuits and modules that enable cost effective, high performance digital wireless communications and connectivity for a broad range of voice and data applications.

     We were founded in 1983 and until 2000, we were a supplier of advanced analog and mixed signal integrated circuits to the computer, communications, telecommunications, consumer and industrial markets. During 2000, we divested our manufacturing test operation and our non-communication product lines and focused our marketing, engineering and product development on new communications products. Product emphasis is the wireless sector, focusing on total ISM (Industrial, Scientific and Medical - 900 MHz, 2.4 GHz and 5.8 GHz) band solutions for applications including digital cordless telephones, wireless headsets, wireless game controllers, and industrial wireless products. Micro Linear is headquartered in San Jose, CA with sales offices around the world.

Fiscal Year

     We report results of operations on the basis of fifty-two or fifty-three week periods, ending on the Sunday closest to December 31. Fiscal year 2002 ended on December 29, 2002. The second quarter of 2002 ended on June 30, 2002. The second quarter of 2003 ended on June 29, 2003. For presentation purposes, the accompanying financial statements refer to the calendar year end and month end of each respective period.

Principles of Consolidation

     The consolidated financial statements include the accounts of Micro Linear Corporation and our subsidiary in the United Kingdom. All significant inter-company accounts and transactions have been eliminated.

     The Company has designated the U.S. dollar as the functional currency for its United Kingdom subsidiary since that subsidiary is dependent on the parent company’s economic environment. The gains and losses resulting from the translation of the United Kingdom subsidiary are recorded as other income and expense. For the first and second quarters of 2002 and 2003, translation gains and losses were not significant.

Basis of Presentation

     The consolidated financial statements included herein have been prepared by us in accordance with accounting principles generally accepted in the United States of America and reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary to state fairly our financial position, results of operations, and cash flows for the periods presented.

     The accompanying unaudited consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q, and therefore do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with generally accepted accounting principles. The unaudited consolidated condensed financial statements and notes should be read in conjunction with the consolidated financial statements and notes in the Annual Report on Form 10-K for the year ended December 29, 2002, filed with the Securities and Exchange Commission on March 27, 2003.

Use of Estimates

     The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates, and such differences may be material to the financial statements.

Net Income (Loss) Per Share

6


Table of Contents

     Basic earnings (loss) per share is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted earnings (loss) per share excludes potential common stock if the effect is anti-dilutive. Diluted net earnings (loss) per share includes the effect of all potentially dilutive common stock outstanding during the period. We compute diluted earnings (loss) per share using the treasury stock method for stock options outstanding.

     A total of 3,271,103 and 4,388,018 shares of potential common stock were not included in the dilutive net loss per share calculations for the periods ending June 30, 2003 and 2002, because to include them would be anti-dilutive.

     Following is a reconciliation of the basic and diluted loss per share computations (in thousands, except per share amounts):

                                   
      Three Months Ended   Six Months Ended
      June 30   June 30
     
 
      2003   2002   2003   2002
     
 
 
 
Basic:
                               
 
Net loss
  $ (3,302 )   $ (1,150 )   $ (5,949 )   $ (3,895 )
 
   
     
     
     
 
 
Weighted average common shares outstanding
    12,213       12,064       12,204       12,063  
 
   
     
     
     
 
 
Basic loss per share
  $ (0.27 )   $ (0.10 )   $ (0.49 )   $ (0.32 )
 
   
     
     
     
 
Diluted:
                               
 
Net loss
  $ (3,302 )   $ (1,150 )   $ (5,949 )   $ (3,895 )
 
   
     
     
     
 
 
Weighted average common shares outstanding
    12,213       12,064       12,204       12,063  
 
Dilutive stock options
                       
 
   
     
     
     
 
 
Weighted average common shares outstanding
    12,213       12,064       12,204       12,063  
 
   
     
     
     
 
 
Diluted loss per share
  $ (0.27 )   $ (0.10 )   $ (0.49 )   $ (0.32 )
 
   
     
     
     
 

Stock-Based Compensation

     We account for our employee stock option plans in accordance with Accounting Principles Board No. (“APB”) 25, “Accounting for Stock Issued to Employees.” Under APB No. 25, compensation cost is measured as the excess, if any, of the quoted market price of our stock at the date of grant over the exercise price of the option granted. Compensation cost for stock options, if any, is recognized ratably over the vesting period. We provide additional pro forma disclosures as required under Statement of Financial Accounting Standards (“SFAS”)  No. 123, “Accounting for Stock-Based Compensation” and SFAS No. 148, “Accounting for Stock-Based Compensation, Transition and Disclosure” in Note 1: Pro Forma Net Income (Loss) Per Share.

     We account for stock issued to non-employees in accordance with the provisions of SFAS No. 123. Stock option awards issued to non-employees are accounted for at fair value using the Black-Scholes option pricing model. The fair value of each non-employee stock award is re-measured at each period end until a commitment date is reached, which is generally the vesting date.

Pro Forma Net Income (Loss) Per Share

     As required by SFAS No. 123, we disclose our pro forma net income (loss) as if we had accounted for our employee stock purchase plan, employee stock options and director stock options subsequent to December 31, 1994 under the fair value method as prescribed in SFAS No. 123. We estimate the fair value for these options at the date of grant using the Black-Scholes option pricing model and the multiple option approach with the following weighted-average assumptions:

                                                 
    Employee Stock                                
    Purchase Plan   Stock Option Plans
   
 
    Six Months Ended   Three Months Ended   Six Months Ended
    June 30,   June 30,   June 30,
   
 
 
    2003   2002   2003   2002   2003   2002
   
 
 
 
 
 
Expected life (in years)
    0.5       0.5       2.5       2.3       2.5       2.3  
Risk-free interest rate
    1.19 %     1.74 %     2.68 %     3.21 %     2.61 %     3.19 %
Volatility
    0.74       0.86       0.79       0.85       0.79       0.85  
Dividend yield
                                   

7


Table of Contents

     The Black-Scholes option valuation model was intended for use in estimating the fair value of publicly traded options that have no vesting restrictions and are fully transferable, which differs significantly from the terms of our stock option awards. In addition, option valuation models require the input of highly subjective assumptions, including the expected stock price volatility and the expected life of the options before exercise, which greatly affect the calculated grant date fair value. There were no shares granted under the Employee Stock Purchase Plan during the three months ended June 30, 2003 and 2002. The weighted average estimated fair values of shares at the date of grant that were issued under the Employee Stock Purchase Plan during the six months ended June 30, 2003 and 2002 were $1.09 and $1.10, respectively. The weighted average fair values at the date of grant of options which were granted under the employee and directors’ stock option plans during the three months ended June 30, 2003 and 2002 were $1.66 and $1.28 respectively. The weighted average fair values at the date of grant of options that were granted under the employee and director stock option plans during the six months ended June 30, 2003 and 2002 were $1.75 and $1.29, respectively.

     SFAS No. 148 amended SFAS No. 123 in December 2002 to require that disclosures of the pro forma effect of using the fair value method of accounting for stock-based employee compensation be displayed more prominently and in a tabular format. The following table illustrates the effect on our net income (loss) and net income (loss) per share if we had recorded compensation costs based on the estimated grant date fair value as defined by SFAS No. 123 for all granted stock-based awards.

                                   
      Three Months Ended June 30   Six Months Ended June 30
     
 
      2003   2002   2003   2002
     
 
 
 
Net loss, as reported
  $ (3,302 )   $ (1,150 )   $ (5,949 )   $ (3,895 )
Add: Stock-based employee compensation expense included in reported net loss, net of tax
    1       33       2       112  
Deduct: Stock-based compensation expense determined under fair value based method for all awards, net of tax
  $ 8     $ (909 )   $ (365 )   $ (1,595 )
 
   
     
     
     
 
Pro forma net loss
  $ (3,293 )   $ (2,026 )   $ (6,312 )   $ (5,378 )
 
   
     
     
     
 
Pro forma net loss per share:
                               
 
Basic
  $ (0.27 )